How much funding has Brii Biosciences raised?

Brii Biosciences has raised $865.0M in total funding, most recently a Venture Round.

Who are Brii Biosciences's investors?

Brii Biosciences's investors include Invesco Real Estate, ARCH Venture Partners, GIC, Lake Bleu Capital, Sequoia Capital, 6 Dimensions Capital.

When was Brii Biosciences founded?

Brii Biosciences was founded in 2018.

Where is Brii Biosciences headquartered?

Brii Biosciences is headquartered in San Francisco Bay Area, California, United States.

What industry is Brii Biosciences in?

Brii Biosciences operates in Biotech, Healthcare.

How many employees does Brii Biosciences have?

Brii Biosciences has 51-200 employees.

Brii Biosciences

IPO

To tackle public health challenges through breakthrough scientific innovation and critical patient insights

Public · San Francisco Bay Area, United States · Founded 2018 · $865.0M raised

Biotech

Healthcare

Headquarters: San Francisco Bay Area, California
Employees: 51–200
Founded: 2018
Business Model: Other
Website: briibio.com

Total Funding: $865.0M
Last Round: $450.0M Venture RoundMay 2025
Rounds: 3
Type: Public

About

Brii Biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious diseases and central nervous system diseases, the company has built a robust pipeline based on patient insights.

Summary

Brii Biosciences is a Biotech company based in San Francisco Bay Area, United States, founded in 2018. It has raised $865.0M in total across 3 rounds, most recently a $450.0M Venture Round round in May 2025. Investors include Invesco Real Estate, ARCH Venture Partners and GIC.